Auxly Cannabis Group (XLY) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
Achieved net revenue of $151.5 million for 2025, up 24% year-over-year, and $40.1 million in Q4 2025, up 16% from Q4 2024.
Adjusted EBITDA grew 64% to $43.8 million for the year, with a margin of 29%; Q4 Adjusted EBITDA was $12.5 million, up 14% year-over-year.
Net income for 2025 was $41.9 million, a $58.2 million improvement from 2024, with EPS of $0.03.
Back Forty was the top cannabis brand in Canada for 2025; launched new premium brand South Point in Alberta and Ontario.
Ended Q4 with $32.3 million in cash and total debt of $46 million.
Financial highlights
Gross Margin on Finished Cannabis Inventory Sold improved to 54% for 2025 (from 46% in 2024); Q4 margin was 56%.
SG&A expenses rose 22% to $43.4 million for the year, reflecting investments to support higher sales.
Cash flow from operations before working capital changes was $38.6 million for 2025, representing 88% conversion from Adjusted EBITDA.
Total assets at year-end were $272 million, up 4% year-over-year.
Outlook and guidance
Focus remains on sustainable, profitable growth, innovation, and operational excellence in Canada.
Plans to invest $10–12 million in 2026 to enhance quality and throughput at Auxly Leamington and prepare for international distribution.
Expects to fund innovation and capacity increases from operating cash flow and maintain profitability through cost control.
Sees long-term growth potential in international markets and is evaluating export opportunities.
Latest events from Auxly Cannabis Group
- Delivered 24% revenue growth in 2025 and leads Canadian cannabis with top brands and innovation.XLY
Investor presentation26 Mar 2026 - Q1 2025 saw 29% revenue growth, 48% gross margin, and a return to profitability, but liquidity risks persist.XLY
Q1 202511 Feb 2026 - Record Q2 2025 revenue, profit, and margins, with strong outlook and market leadership.XLY
Q2 202510 Feb 2026 - Net loss narrowed and debt fell, but going concern risk persists amid negative working capital.XLY
Q4 202410 Feb 2026 - Q3 2024 revenue, profit, and market share rose, but liquidity and debt risks persist.XLY
Q3 202410 Feb 2026 - Record Q2 revenue and margin gains, but going concern risks persist.XLY
Q2 202410 Feb 2026 - Record Q3 2025 results and innovation position the company for growth at home and abroad.XLY
Small Cap Growth Virtual Investor Conference 202513 Dec 2025 - Q3 2025 delivered strong revenue and profit growth, with improved margins and reduced debt.XLY
Q3 202513 Nov 2025 - Record Q2 results and recapitalization position the company for profitable, efficient growth.XLY
Planet MicroCap Showcase: TORONTO 202523 Oct 2025